Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 6, Number 1—February 2000

Integronlike Structures in Campylobacter spp. of Human and Animal Origin

Brigid Lucey*†, D. Crowley*, P. Moloney‡, B. Cryan†, M. Daly*, F. O'Halloran*, E.J. Threlfall§, and S. Fanning*Comments to Author 
Author affiliations: *Cork Institute of Technology, Bishopstown, Cork, Ireland; †Cork University Hospital, Cork, Ireland; ‡Cork Corporation Veterinary Department, Cork, Ireland; §PHLS Central Public Health Laboratory, London, United Kingdom

Main Article


Isolates of Campylobacter coli and C. jejuni from which gene cassettelike structures were amplified

Isolate No. Yeara R-type IP-profile Isolate No. Yeara R-type IP-profile
Campylobacter jejuni C. jejuni, cont’d
CIT-H6 1997 SpSuTm I CIT-H1 1996 SpSuTm VIII
CIT-H7 1996 SpTm I CIT-P1 1997 SpSuTm IX
CIT-H8 1997 ApSpTm I CIT-H2 1996 SpSuTm X
CIT-H9 1997 SpTm I CIT-H3 1997 SuTTm XI
CIT-H10 1997 Tm I CIT-H4 1996 SpSuTm XII
CIT-H12 1997 NaSpTm I CIT-H5 1997 SuTm XIII
CIT-H14 1997 SpTm I C. coli
CIT-H15 1996 SpTm I CIT-P3 1996 EGSSpSuTm XIV
CIT-H16 1997 SpTTm I CIT-V3 1998 ESpTTm XIV
CIT-H22 1996 SpSuTm I CIT-V6 1998 CCpENaSSpTTm XIV
CIT-H25 1997 SSpTm I CIT-V1 1998 SpSuTm XV
CIT-H26 1997 ApSpTm I CIT-V4 1998 SSpTTm XVI
CIT-P4 1997 TTm I CIT-V5 1998 ESSuTTm XVI
CIT-P5 1997 SpSuTm I CIT-V2 1998 ESSpSuTTm XVI
CIT-H30 1997 SuTTm I C. jejuni
CIT-H31 1996 SpSuTm I CIT-H23 1996 SpSuTm XVII
CIT-P10 1997 SpTm I CIT-H28 1997 CtTm XVIII
CIT-P13 1996 NaTm I C. coli
CIT-P14 1996 SuTTm I CIT-P2 1997 SpSuTm XIX
CIT-P15 1996 SpSuTTm I C. jejuni
CIT-P16 1996 ApSpSuTTm I CIT-H19 1997 SpSuTm XX
CIT-H29 1997 SuTm II CIT-H17 1996 ApCtENaSSpSuTTm XI
CIT-P7 1997 NaSuTm II CIT-H21 1997 SpSuTm XXI
CIT-P8 1997 SpSuTm II CIT-H32 1996 SSpSuTm XXI
CIT-P9 1997 / II CIT-H18 1997 ApCtSSpSuTm XXII
CIT-P6 1997 SpSuTm III CIT-H20 1996 ApSpTm XXII
CIT-P11 1996 NaSpTm III Control strainsb
CIT-P17 1997 ESpSuTm III Escherichia coli
CIT-H11 1997 ApSpSuTm IV [R100.1] / / A
CIT-H13 1997 ApCSpTm IV E. cola
CIT-P12 1996 CtNaSpSuTTm V [R751] / / B
CIT-H24 1997 ApNaTm VI Salmonella Typhimurium
CIT-H27 1997 NaSSpSuTm VII CIT-F 100 1998 ACSSuT C

aYear of isolation.
bE. coli and Salmonella enterica serotype Typhimurium control strains. The former carried plasmids R100.1 and R752, respectively, provided by D. Sandvang (13). S. Typhimurium DT104 [CIT-F 100] was previously characterized by M. Daly et al. (14).
H, hospital isolate; P, poultry isolate; V, veterinary isolate; /, not available or not determined. Antimicrobial agents: Ap, ampicillin; C, chloramphenicol; Cp, ciprofloxacin; Ct, colistin; E, erythromycin; G, gentamicin; Na, nalidixic acid; S, streptomycin; Sp, spectinomycin; Su, sulphafurazole; T, tetracycline; Tm, trimethoprim.

Main Article

  1. Stern  NJ. Reservoirs for Camplobacter jejuni and approaches for intervention in poultry. In: Nachamkin I, Blaser MJ, Tompkins LS, editors. Campylobacter jejuni: current status and future trends. Washington: American Society for Microbiology; 1992. p. 49-60.
  2. Skirrow  MB. Diseases due to Campylobacter, Helicobacter and related bacteria. J Comp Pathol. 1994;111:11349. DOIPubMedGoogle Scholar
  3. Nachamkin  I, Allos  BM, Ho  T. Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev. 1998;11:55567.PubMedGoogle Scholar
  4. Recchia  GD, Hall  RM. Gene cassettes: a new class of mobile element. Microbiology. 1995;141:301527. DOIPubMedGoogle Scholar
  5. Hall  RM, Collis  CM. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol. 1995;15:593600. DOIPubMedGoogle Scholar
  6. Moore  JE, Elisha  BG. Workshop summary: session D. Campylobacter and Helicobacter: antibiotic resistance. In: Lastovica AJ, Newell DG, Lastovica EE, editors. Campylobacter, Helicobacter & related organisms, Institute of Child Health, University of Cape Town; 1998. p. 133-5.
  7. Ruiz  J, GoZi  P, Marco  F, Gallardo  F, Mirelis  B, De Anta  TJ, . Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol. 1998;42:2236.PubMedGoogle Scholar
  8. Sjögren  E, Kaijser  B, Werner  M. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother. 1992;36:28479.PubMedGoogle Scholar
  9. Reina  J, Ros  MJ, Serra  A. Susceptibilities to ten antimicrobial agents of 1,120 Campylobacter strains isolated from 1987 to 1993 from faeces of paediatric patients. Antimicrob Agents Chemother. 1994;39:291020.
  10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Vol. 1, p: 141-56 (1981). Approved standard. National Committee for Clinical Laboratory Standards, Villanova, Pa.
  11. Mazurier  S, Van de Giessen  A, Heuvelman  K, Wernars  K. RAPD analysis of Campylobacter isolates: DNA fingerprinting without the need to purify DNA. Lett Appl Microbiol. 1992;14:2602. DOIPubMedGoogle Scholar
  12. Levesque  C, Pichè  L, Larose  C, Roy  P. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother. 1995;39:18591.PubMedGoogle Scholar
  13. Sandvang  D, Aarestrup  FM, Jensen  LB. Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica typhimurium DT104. FEMS Microbiol Lett. 1998;160:3741. DOIPubMedGoogle Scholar
  14. Daly  M, Buckley  J, Power  E, O'Hare  C, Cormican  M, Cryan  B, Molecular characterization of Irish Salmonella enterica serotype Typhimurium: detection of class 1 integrons and assessment of genetic relationships by DNA fingerprinting. Appl Environ Microbiol. 2000. In press.
  15. Gibreel  A, Sköld  O. High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases. Antimicrob Agents Chemother. 1998;42:305964.PubMedGoogle Scholar
  16. Briggs  C, Fratamico  PM. Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104. Antimicrob Agents Chemother. 1999;43:8469. DOIPubMedGoogle Scholar
  17. Altschul  SF, Madden  TL, Schäffer  AA, Zhang  J, Zhang  Z, Miller  W, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389402. DOIPubMedGoogle Scholar
  18. Wang  Y, Taylor  DE. Natural transformation in Campylobacter species. J Bacteriol. 1990;172:94955.PubMedGoogle Scholar
  19. Jackson  CJ, Fox  AJ, Jones  DM, Wareing  DRA, Hutchinson  DN. Associations between heat-stable (O) and heat-labile (HL) serogroup antigens of Campylobacter jejuni: evidence for interstrain relationships within three O/HL serovars. J Clin Microbiol. 1998;36:22238.PubMedGoogle Scholar
  20. On  SLW, Nielsen  EM, Engberg  J, Madsen  M. Validity of SmaI-defined genotypes of Campylobacter jejuni examined by SalI, KpnI, and BamHI polymorphisms: evidence of identical clones infecting humans, poultry, and cattle. Epidemiol Infect. 1998;120:2317. DOIPubMedGoogle Scholar
  21. Richardson  PT, Park  SF. Integration of heterologous plasmid DNA into multiple sites on the genome of Campylobacter coli following natural transformation. J Bacteriol. 1997;179:180912.PubMedGoogle Scholar
  22. Kokotovic  B, On  SLW. High-resolution genomic fingerprinting of Campylobacter jejuni and Campylobacter coli by analysis of amplified fragment length polymorphisms. FEMS Microbiol Lett. 1999;173:7784. DOIPubMedGoogle Scholar
  23. Sallen  B, Rajoharison  A, Desvarenne  S, Mabilat  C. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of Enterobacteriaceae. Microb Drug Resist. 1995;1:195202. DOIPubMedGoogle Scholar

Main Article

Page created: May 09, 2011
Page updated: May 09, 2011
Page reviewed: May 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.